Cognitive Behavioral Group Therapy for the Management of Menopause Symptoms in Mood Disorders
- Conditions
- MenopauseBipolar DisorderMajor Depressive Disorder
- Registration Number
- NCT02860910
- Lead Sponsor
- Danette Conklin, PhD
- Brief Summary
The general objective of this study is to advance insight into non-pharmacological treatments for maturing women that impact psychological health and wellbeing of women adapting to menopause, a natural but often challenging developmental milestone.
- Detailed Description
This exploratory study proposes to expand the knowledge in the menopausal literature and evaluate the effectiveness of cognitive-behavioral group therapy (CBGT) in reducing problematic vasomotor symptoms, reducing daily interference and improving quality of life. The study will include two homogenous peri- or post-menopausal cohorts (African-American and Caucasian) with major depressive disorder or bipolar disorder. The intervention will be delivered in groups of 6 to 10 participants per group of both race/ethnicities in an outpatient setting during a 6-week time period. The participants will be assessed on the degree of hot flash problem rating, hot flash related daily interference, and menopause quality of life at screening, baseline, and post-treatment. Participants will also be assessed using the following predictor variables at the same time points: body mass index (BMI), level of perceived stress, severity of depression, severity of anxiety level of pleasure, severity of mania, hot flash beliefs and severity of couple's conflict.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 59
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Number of participants who begin cognitive group behavioral therapy 2 years Change in Hot Flush Rating Scale: Frequency and Problem Rating (HFRS) total score Baseline and Week 6
- Secondary Outcome Measures
Name Time Method Change in Menopause Representation Questionnaire (MRQ) total score Baseline and Week 6 Change in Hot Flash Daily Interference Scale (HFRDIS) total score Baseline and Week 6
Trial Locations
- Locations (1)
University Hospitals Cleveland Medical Center - Mood Disorders Program
🇺🇸Cleveland, Ohio, United States
University Hospitals Cleveland Medical Center - Mood Disorders Program🇺🇸Cleveland, Ohio, United States